SIGY (Sigyn Therapeutics) General and Admin. Expense: $1.74 Mil (TTM As of Sep. 2025)


What is Sigyn Therapeutics General and Admin. Expense?

Sigyn Therapeutics SIGY +22.62% General and Admin. Expense is $1.74 Mil as of Sep. 2025. The stock has 3 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Sigyn Therapeutics's General and Admin. Expense for the three months ended in Sep. 2025 was $0.36 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2025 was $1.74 Mil.

Sigyn Therapeutics General and Admin. Expense Related Terms

Sigyn Therapeutics General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Sigyn Therapeutics's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sigyn Therapeutics General and Admin. Expense Chart

Sigyn Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.50 1.27 1.49 1.66 1.75

Sigyn Therapeutics Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 0.38 0.54 0.46 0.36

Sigyn Therapeutics General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of $1.74 Mil mean?
Sigyn Therapeutics (SIGY) has a General and Admin. Expense of $1.74 Mil as of Sep. 2025. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Sigyn Therapeutics and its competitors.
Is Sigyn Therapeutics' General and Admin. Expense too high?
Sigyn Therapeutics' current General and Admin. Expense is $1.74 Mil.
How does Sigyn Therapeutics' General and Admin. Expense compare to RGBP and ENDV?
Sigyn Therapeutics' General and Admin. Expense of $1.74 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Biotechnology company?
A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Sigyn Therapeutics and its competitors. Sigyn Therapeutics's current General and Admin. Expense is $1.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigyn Therapeutics stock overvalued right now?
Sigyn Therapeutics (SIGY) has a current General and Admin. Expense of $1.74 Mil. The current General and Admin. Expense is $1.74 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Sigyn Therapeutics (SIGY), the current General and Admin. Expense is $1.74 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sigyn Therapeutics Business Description

Address 2468 Historic Decatur Road, Suite 140, San Diego, CA, USA, 92106
Sigyn Therapeutics Inc is a development-stage therapeutic technology company. Its business focus is the clinical advancement of Sigyn Therapy, a multi-function blood purification technology designed to overcome the limitations of previous drugs and devices to treat life-threatening inflammatory disorders, including sepsis, the cause of hospital deaths world-wide. To support widespread implementation, the company designed Sigyn Therapy to be a single-use disposable device that is deployable on the world-wide infrastructure of hemodialysis and continuous renal replacement therapy machines already located in hospitals and clinics.